Cosmos Health Inc. (NASDAQ:COSM) Short Interest Update

Cosmos Health Inc. (NASDAQ:COSMGet Free Report) saw a significant growth in short interest in March. As of March 31st, there was short interest totalling 547,800 shares, a growth of 188.8% from the March 15th total of 189,700 shares. Currently, 3.6% of the company’s stock are sold short. Based on an average daily trading volume, of 281,100 shares, the short-interest ratio is presently 1.9 days.

Insider Buying and Selling

In other Cosmos Health news, CEO Grigorios Siokas purchased 60,000 shares of Cosmos Health stock in a transaction dated Friday, February 16th. The shares were acquired at an average cost of $0.83 per share, with a total value of $49,800.00. Following the completion of the transaction, the chief executive officer now owns 1,394,597 shares in the company, valued at approximately $1,157,515.51. The transaction was disclosed in a filing with the SEC, which is available at this link. 18.74% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Cosmos Health

A number of large investors have recently made changes to their positions in the business. Armistice Capital LLC purchased a new stake in shares of Cosmos Health during the fourth quarter valued at $1,882,000. BlackRock Inc. grew its holdings in shares of Cosmos Health by 9.0% during the second quarter. BlackRock Inc. now owns 291,914 shares of the company’s stock valued at $873,000 after buying an additional 24,117 shares during the last quarter. Vanguard Group Inc. purchased a new stake in shares of Cosmos Health during the third quarter valued at $212,000. Geode Capital Management LLC purchased a new stake in shares of Cosmos Health during the first quarter valued at $327,000. Finally, Virtu Financial LLC grew its holdings in shares of Cosmos Health by 444.0% during the second quarter. Virtu Financial LLC now owns 87,969 shares of the company’s stock valued at $33,000 after buying an additional 71,799 shares during the last quarter. 12.61% of the stock is owned by institutional investors and hedge funds.

Cosmos Health Stock Performance

Shares of COSM stock traded down $0.02 during trading hours on Friday, reaching $0.71. 115,835 shares of the company’s stock were exchanged, compared to its average volume of 269,576. The stock’s 50 day moving average is $0.76 and its 200-day moving average is $1.03. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.79 and a current ratio of 2.06. Cosmos Health has a fifty-two week low of $0.61 and a fifty-two week high of $4.05.

Analysts Set New Price Targets

Separately, Taglich Brothers reaffirmed a “speculative buy” rating on shares of Cosmos Health in a research report on Tuesday, February 20th.

Check Out Our Latest Analysis on COSM

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.

Read More

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.